期刊文献+

HBVcccDNA在乙型肝炎患者血清、外周单核细胞及肝组织中的分布 被引量:7

HBVcccDNA of patients with hepatitis B in the serum, PBMC and liver tissue distribution
原文传递
导出
摘要 目的观察乙肝病毒共价闭合环状DNA(HBVcccDNA)在乙肝患者血清、外周单核细胞(PBMC)及肝组织中的分布情况。方法选取血清HBVDNA〉10^5拷贝/ml的乙肝患者50例,血清HBVDNA〈10^5拷贝/ml的乙肝患者30例,脂肪肝患者(非乙型肝炎)20例,同时采用实时荧光定量聚合酶链反应检测患者血清、PBMC及肝组织中HBVcccDNA的存在情况。结果50份血清HBVDNA〉10^5拷贝/ml的标本中血清HBVcccDNA检出28例,检出率56%,PBMC HBVcccDNA检出29例,检出率58%,肝组织中HBVcccDNA检出44例,检出率88%,血清、PBMC的检出较肝组织检出差异有统计学意义P〈0.005,血清较PBMC检出差异无统计学意义P〉0.005。30份血清HBVDNA〈10^5拷贝/ml的标本中血清、PBMC HBVcccDNA检出均为2例,检出率6.67%,肝组织中HBVcccDNA检出6例,检出率20%,血清、PBMC、肝组织三者之间检出差异无统计学意义,P〉0.005。20份脂肪肝患者的血清、PBMC及肝组织中均未检出HBVcccDNA。结论HBVcccDNA主要存在于乙型肝炎患者的肝脏中,乙肝患者血清及PBMC中也有HBVcccDNA的存在但较肝组织中要少的多。 Objective Hepatitis B virus covalently closed circular DNA in the serum of patients with hepatitis B, peripheral mononuclear cells (PBMC) and liver tissue distribution. Methods Serum HBV DNA 〉 105 copies/ml 50 cases of hepatitis B patients, serum HBV DNA 〈 105 copies/ml 30 cases of hepatitis B patients, patients with fatty liver (hepatitis B) 20 eases, using real-time quantitative polymerase chain reaction for detection of serum, and liver tissue in PBMC HBVcccDNA the existence. Results Of 50 serum HBV DNA 〉 105 copies/ml cecDNA the serum specimens were 28 cases, 56% detection rate, 29 cases were PBMC HBVcccDNA, 58% detection rate, liver tissue HBVcccDNA were 44 cases, 88% detection rate, serum, the PBMC were detected in liver tissue were significant differences in P 〈 0.005, compared serum PBMC were no significant differences in P 〉0.005. 30 serum HBV DNA 〈 105copies/ml the serum specimens, PBMC eccDNA detected two cases were 6.67% detection rate, liver tissue cccDNA were six cases 20% detection rate, serum, PBMC, were among the liver tissue was not significantly different P 〉 0.005. 20 in the serum of patients with fatty liver, liver tissue in PBMCwere not detected HBVcccDNA. Conclusion HBVcccDNA mainly in the liver of patients with hepatitis B, hepatitis B patients and also cccDNA PBMC in the presence of liver tissue but a few of many.
出处 《中华实验和临床病毒学杂志》 CAS CSCD 北大核心 2008年第5期342-344,共3页 Chinese Journal of Experimental and Clinical Virology
基金 杭州市科技局科研项目(2004433Q03) 杭州市卫生局重点传染专科课题
关键词 单核细胞 DNA Monocytes Liver DNA
  • 相关文献

参考文献5

二级参考文献36

  • 1Lin Zhuang Jing You Bao Zhang Tang Su Ying Ding Kui Hua Yan Dan Peng Yan Mei Zhang Lu Zhang ~1Department of Hepatology,Kunming Third Municipal Peoples Hospital,Kunming 650041,Yunnan Province,China ~2Department of Infectious Diseases,The First Affiliated Hospital of Kunming Medical College,Kunming 650032,Yunnan Province,China.Preliminary results of Thymosin-a1 versus interferon-α treatment in patients with HBeAg negative and serum HBV DNA positive chronic hepatitis B[J].World Journal of Gastroenterology,2001,7(3):407-410. 被引量:24
  • 2Zhao-You Tang Liver Cancer Institute & Zhongshan Hospital of Fudan University Professor of Surgery Chairman.Liver Cancer Institute of Fudan University(previous Liver Cancer Institute of Shanghai Medical University)136 Yixueyuan Road,Zhongshan Hospital,Shanghai 200032,China..Hepatocellular Carcinoma-Cause,Treatment and Metastasis[J].World Journal of Gastroenterology,2001,7(4):445-454. 被引量:214
  • 3郎振为,闫惠平,黄德在,王健,吴和,Zhang JL,Perry A,Byrne SK,Stiver GH.聚合酶链反应检测乙型肝炎患者肝外组织中的乙型肝炎病毒DNA[J].中华内科杂志,1994,33(4):232-236. 被引量:33
  • 4骆抗先.实验感染模型[A].骆抗先主编.乙型肝炎基础和临床:第2版[C].北京:人民卫生出版社,2001.74-84.
  • 5Lu X, Block TM, Gerlich WH. Protease-induced infectivity of hepatitis B virus for a human hepatoblastoma cell line. J Virol,1996, 70:2277-2285.
  • 6Addison WR, Walters KA, Wong WW, et al. Half-life of the duck hepatitis B virus covalently closed circular DNA pool in vivo following inhibition of viral replication. J Virol, 2002, 76:6356-6363.
  • 7He ML, Wu J, Chen Y, et al. A new and sensitive method for the quantification of HBV cccDNA by real-time PCR. Biochem Biophys Res Commun, 2002, 295:1102-1107.
  • 8Sells MA, Chen ML, Acs G. Production of hepatitis B virus particles in HepG2 cells transfected with cloned hepatitis B virus DNA. Proc Natl Acad Sci, 1987, 84:1005-1009.
  • 9Sells MA, Zelent AZ, Shvartsman M, et al. Replicative intermediates of hepatitis B virus in HepG2 cells that produce infectious virions. J Virol, 1988, 62:2836-2844.
  • 10Lampertico P, Malter JS, Gerber MA. Development and application of an in vitro model for screening anti-hepatitis B virus therapeutics. Hepatology, 1991, 13:422-426.

共引文献158

同被引文献39

引证文献7

二级引证文献24

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部